Aussie Study Says Some Long-Term Drug Use Harmful To Elderly
This article was originally published in PharmAsia News
Executive Summary
An Australian study concluded many drugs commonly used by the elderly are useless in the long term and may even retard improvement in some conditions. The study by the University of Sydney pointed to drugs that affect the brain and nervous system as particular instances where improvement actually results from behind taken off drugs after a while. It said patients taken off sleeping pills and antidepressants after a while saw improvement in their mental abilities and were less likely to fall down. Blood-pressure drugs also were unnecessary for 85 percent of patients aged 65 and older as long as six months to five years after being taken off the drugs and that sector recorded no increase in death rate, the study said. The lead researcher said many drugs have not been studied sufficiently in elderly people. (Click here for more
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.